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The tumor marker carcinoembryonic antigen (CEA) belongs to a family of proteins which are
composed of one immunoglobulin variable domain and a varying number of immunoglobulin con-
stant-like domains. Most of the membrane-bound members, which are anchored either by a glycosyl-
phosphatidylinositol moiety or a transmembrane domain, have been shown to convey cell adhesion
in vitro. Here we describe two splice variants of CGMl, a transmembrane member of the CEA
family without immunoglobulin constant-like domains. CGMla and CGMlc contain cytoplasmic
domains of 71 and 31 amino acids, respectively. The cytoplasmic region of CGMla is encoded by
four exons (Cytl-Cyt4). Differential splicing of the Cytl exon (53 bp) leads to the formation of
CGMlc. The presence or absence of potential protein kinase phosphorylation sites in the cytoplas-
mic domains and a sequence consensus motif involved in signal transduction in multichain immune
recognition receptors indicates that this splice event is of functional importance. CGMla mRNA,
the predominant CGMI transcript, was found in the granulocytic lineage, but not in monocytes,
lymphocytes nor in a number of tumors derived from all three germ layers. Weak staining using
monoclonal antibodies Tu2 and 73 in fluorescence-activated cell scan analyses indicate low concen-
trations of CGMl protein on the surface of granulocytes. The CGMl protein is also recognized by
CD66 antibodies. Therefore, the granulocyte-specific CD66 epitope is present on at least four CEA
family members; CGMl, CEA, NCA-50/90 and NCA-160.
The carcinoembryonic antigen (CEA) gene family enco-
des the widely used tumor marker CEA (Shively and Beatty,
1985), as well as a number of closely related membrane-
bound glycoproteins, some of which convey homophilic
[CEA, nonspecific crossreacting antigen (NCA), biliary gly-
coprotein (BGP)] and/or heterophilic cell adhesion (CEA,
NCA, BGP, CGM6) in vitro (Benchimol et al., 1989; Oikawa
et al., 1989, 1991; Rojas et al., 1990; Zhou et al., 1990). As
members of the immunoglobulin superfamily (Paxton et al.,
1987), they consist of one N-terminal, immunoglobulin vari-
able-like (IgV), and a varying number (0, 2, 3, 6) of immuno-
globulin constant-like (IgC) domains (reviewed by Thomp-
son et al., 1991). They are anchored to the cell membrane
either via a glycosylphosphatidylinositol moiety (CEA,
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Note. The novel nucleotide sequence data published here have
been deposited with the GenBank (Los Alamos) sequence data bank
and are available under the accession numbers L(X)692 and LC)0693.
NCA, CGM6) or have a hydrophobic transmembrane region
(BGP). For BGP as well as for its rat (ecto ATPase) and
mouse homologues (mmCGMl/2), isoforms have been de-
scribed which differ in the length of their cytoplasmic do-
mains (Bamett et al., 1989; Lin and Guidotti, 1989;
McCuaig et al., 1992; Culic et al., 1992). The intracellular
domains of human and rat BGP isoforms are phosphorylated
(Afar et al., 1992; Culic et al., 1992). Furthermore, the intra-
cellular domain of the rat homologue has been shown to be
a substrate of the insulin receptor tyrosine kinase (Margolis
et al., 1990). Although the functional significance of this ob-
servation is unclear, it suggests that the transmembrane mem-
bers of the CEA family might be involved in signal transduc-
tion.
CEA-related antigens reveal high sequence similarities as
deduced from cDNA and genomic cloning data, but they are
differentially expressed (reviewed in Thompson et al., 1991).
For example, CEA is found in different adenocarcinomas and
some normal epithelial tissues. A coexpression of NCA-50/
90 is found in the same adenocarcinomas, but this antigen is
also found in granulocytes, which never express CEA. NCA-
95, on the other hand, seems to be restricted to cells of the
myeloid lineage and has not been found in other tissues
tested thus far (Berling et al., 1990). Recently, it was demon-
strated that the antibodies assigned to the granulocyte-
specific clusters of differentiation (CD), CD66 and CD67
(Knapp et al., 1989), are directed against epitopes expressed
by members of the CEA family. CD66 antibodies were re-
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ported to react with the granulocytic glycoproteins NCA-50/
90 and NCA-160, whereas CD67 antibodies are reactive with
NCA-95 (Watt et al. 1991; Skubitz et al., 1992; van der
Schoot et al., unpublished results). Several other CEA-related
antigens have been described in leukocytes, many of which
have not yet been assigned to specific genes (Kuroki et al.,
1990a,b, 1991, 1992).
Recently, a new CEA-related protein with transmem-
brane anchorage (CGMla) was identified by cDNA cloning
(Kuroki et al., 1991). The mature protein is predicted to con-
sist of only one IgV-like domain, a transmembrane region
and a cytoplasmic tail. Although of similar length, only the
first third of the CGMla cytoplasmic domain shows simi-
larity to the intracellular tail of BGPa (old name: TM-1
CEA) at the amino acid sequence level. It is not known
whether other CGMl isoforms with different cytoplasmic do-
mains like BGPa and BGPc (TM-3 CEA) exist (Barnett et
al., 1989). Furthermore, little is known about the expression
pattem of CGMl and its immunological relationship with
other members of the CEA family.
As a basis for functional analyses of the intracytoplasmic
domain of CEA-related proteins, we have looked for CGMl
splice variants. Here, we describe two CGMl mRNAs cre-
ated by complex differential splicing which encode isoforms
with different cytoplasmic domains. Using the polymerase
chain reaction (PCR) technique and monoclonal antibodies
(mAbs), their expression pattems have been investigated in
different leukocyte subpopulations and in tumors.
MATERIALS AND METHODS
Monoclonal antibodies
The mouse mAb NI was raised against purified NCA-
50. Its specificity has been described before (Schwarz et al.,
1989; Berling et al., 1990). mAbs CLBgran 10, YTH71.3.2
(CD66) and B13.9 (CD67) were characterized at the last
Workshop on Leukocyte Differentiation Antibodies (Knapp
et al., 1989; reagents M38, Ml28, M37 respectively). mAb
Tu2 was purchased from Boehringer Mannheim. mAb 73
was a generous gift from F. Buchegger (Lausanne).
Isolation and characterization of cDNA clones
The anchored polymerase chain reaction (PCR) was used
to isolate full-length cDNA clones. Total RNA (1 ng) from
leukocytes of a chronic myeloid leukemia patient was re-
verse-transcribed with avian myeloblastosis virus reverse
transcripta.se (Promega) using an oligo(dT)-containing oli-
gonucleotide [5'-GGAATTCGTCGACAAGCTT(T),,G/C/A-
3' | as a primer. This primer can hybridize at the ends of all
polyadenylated mRNAs due to the redundancy at its 3' end
(Leibrock et al., 1989) and it contains EcoRl, SaH and Hin-
dlll recognition sites for subcloning. CEA-related cDNAs
were amplified by 30 cycles (denaturation: 1 min, 93°C; an-
nealing: 30 s, 50°C; extension: 3 min, 72°C) in a Thermo-
cycler 60 (Bio-Med) after addition of a CGMl-specific oli-
gonucleotide deduced from the 5'-untranslated region of the
known CGMl gene sequence (Thompson et al., 1989) and
Taq DNA polymerase (Promega) according to Sambrook et
al. (1989). Selection of the gene-specific primer CGMl-5'
(5'-GGAATTCCTGGAGCCCAGGCTCTTT-3') was aided
by the program 'Primer' (Lucas et al., 1991). It differs in at
lea.st three positions compared to the known sequences of the
other members of the CEA gene family. To the 5' end of
this primer, nucleotides were added to generate an EcoRl
restriction site. The longest PCR product with a length of
about 1100 bp was purified by agarose gel electrophoresis
and subcloned into Bluescript (Stratagene). Sequencing was
performed on single- or double-stranded templates with Se-
quenase (United States Biochemicals) or T7 DNA poly-
merase (Pharmacia) using internal or universal oligonucleo-
tide primers. Protein kinase phosphorylation sites were iden-
tified using the sequence analyses package PC/Gene (Intelli-
Genetics Inc.).
Determination of exon structure
The borders of the exons coding for the cytoplasmic do-
main were determined by sequencing. For this purpose a 2.4-
kb genomic fragment was amplified by PCR from cosmid
DNA of clone 8486, which contains the CGMl gene (Tynan
et al., 1992), using oligonucleotides from the transmembrane
domain (MWl, position 568—584) and the 3'-untranslated
region (MW2, position 973-989), subcloned into Bluescript
(pBSCGMl-Cyt) and sequenced with oligonucleotides de-
rived from the cDNA sequence as primers. The distances
between the exons were inferred from the size of the ampli-
fied genomic DNA fragments. Supercoiled cosmid 8486 and
plasmid pBSCGMl-Cyt DNAs were used as template with
5'-oligonucleotides TEXll (A domain, position 629 — 645),
CGMl-Cytl (cytoplasmic domain, position 597-613),
CGM1-Cyt3 (cytoplasmic domain, position 712-728) and
3'-oligonucleotides CGMl-TM (transmembrane region, posi-
tion 520—536), CGMl-Cytlc (cytoplasmic domain, position
617-633), CGMI-Cyt2 (cytoplasmic domain, position
668-680) in the following combinations: TEX 11/CGMl-
TM, TEXll/CGMl-Cytlc, MWl/CGMl-Cytlc, MWl/
CGM1-Cyt2, MW1/MW2, CGM1-Cytl/CGM1-Cyt2,
CGMl-Cytl/MW2, CGMl-Cyt3/MW2. The position num-
bers refer to the CGMlb (TEXll; Kuroki et al., 1991) and
the CGMla sequence (see below), respectively. After sub-
cloning, some of these PCR products were also used for the
determination of exon/intron borders by sequencing. Since
the distance between exons N and A could not be determined
by PCR, the presence of two Kpnl restriction endonuclease
sites in the TM exon and in the 3'-flanking intron, respec-
tively, was exploited to map the position of this exon relative
to the flanking EcoR\ sites. Eor this purpose, the 14.4-kb
EcoRl DNA fragment from cosmid 17104, which hybridizes
with a CEA exon A/B probe (Tynan et al., 1992), the corre-
sponding fragment from cosmid 8486, which is truncated at
its 3'-end, as well as pBSCGMl-Cyt were digested with
Kpnl. The positions of the Kpnl sites were inferred from the
size of the resulting fragments.
RNA analyses
Total RNA was isolated from fresh cells or tissues pul-
verized in liquid nitrogen by the guanidine thiocyanate me-
thod (Eiddes and Goodman, 1979) or by the acid phenol me-
thod of Chomczynski and Sacchi (1987). Reverse transcrip-
tion and PCR for the detection of ^-actin mRNA were per-
formed as described by Lucas et al. (1991). Eor the reverse
transcription reaction, 50 pmol 3'-oligonucleotide (5'-
AGCCATGCCAATCTCATCTTGT-3') derived from the hu-
man /^actin gene was used to prime first-strand DNA syn-
thesis from 0.5 ng total RNA. After denaturation at 93 °C,
the corresponding 5'-oligonucleotide (5'-ACGGCTGCTTC-
CAGCTCCTC-3') was added for PCR. Reverse transcription
for the detection of CGMl mRNA was carried out using
a first-strand cDNA synthesis kit from Pharmacia. CGMl-
specific oligonucleotides for PCR were chosen from the 5'-
untranslated (CGMl-5') and 3'-untranslated region (MW2.
see above). PCR conditions were as described above, except
annealing was for 15 s at 64°C and 54°C for the detection
of yff-actin mRNA and CGMl mRNAs, respectively. Before
analysis by gel electrophoresis, samples were treated with
RNase A (20 ^g/ml) at 37°C for 15 min.
Cells and tissues
HeLa cells were cultured in RPMI 1640, Chinese hamster
ovary (CHO) cells in minimum essential medium a, both
supplemented with 10% fetal calf serum, penicillin and strep-
tomycin. Stable transfectants were cultured in the presence
of 0.5 mg/ml G418 (Gibco-BRL). Human primary tumors,
except gynecological tumors, were propagated in nude mice
and were frozen and stored in liquid nitrogen immediately
after resection. Leukocytes from chronic myeloid leukemia
(CML) patients were isolated from peripheral blood by cen-
trifugation through a Percoll (Pharmacia) step gradient ac-
cording to the manufacturer's protocol and used directly for
RNA isolation. In some cases Ficoll Paque (Pharmacia) in-
stead of Percoll was used for the isolation of peripheral blood
leukocytes. Granulocytes were purified as described before
(Roos and de Boer, 1986). The purity of the granulocytes was
greater than 98%, with >95% ofthe cells being neutrophils.
Lymphocytes and monocytes were purified from the mono-
nuclear cell fraction by countercurrent elutriation (Roos and
de Boer, 1986). Cell purity was greater than 90%.
Stable transfectants
CGMl a cDNA and CEA cDNA (Pelegrin et al., 1992)
were excised from Bluescript (BS KS M13-I-) by double di-
gestion with EcoRl and //mdlll, which cut in the flanking
polylinker region. The inserts were cloned into the ex-
pression vector pBEHpUC9 (Artelt et al., 1988) downstream
of the SV40 early promoter. The construction of the NCA-
50/90 expression vector has been decribed before (Kolbinger
et al., 1989). Transfection of HeLa cells was performed with
minor modifications as described by Feigner et al. (1987).
10" HeLa cells on a 10-cm plastic Petri dish were transfected
using N-H-i2, 3-dioleyloxy)-propyl]-A',A',A'-trimethylam-
monium chloride (DOTMA; Boehringer Mannheim) as
transfection reagent according to the manufacturer's proto-
col. 1 ng pSV2neo plasmid DNA (Southern and Berg, 1982),
which confers resistance toward the neomycin derivative
G418, and 20 ng of the CGMl a expression construct were
incubated together with 30 nl DOTMA in 500 (xl phosphate-
buffered saline (NaCl/P,; 137 mM NaCl, 2.7 mM KCl,
8.1 mM Na2HPO4, 1.8 mM KH.PO^, pH 7.4) for 10 min at
room temperature. HeLa cells were incubated with the trans-
fection mixture in 8 ml RPMI, 10% fetal calf serum for 20 h
at 37°C, 10% CO,. Control cultures were transfected with 1
ng pSV2neo DNA alone. Selection for cells expressing the
bacterial neo gene was carried out in the presence of 0 .5 -
1.0 mg/ml G418. After about 4 weeks, colonies were isolated
using cloning cylinders and analyzed for surface expression
of CGM1 by flow cytometry. The production of CGM6- and
BGPa-expressing transfectants has been described previously
(Berling et al., 1990; Kuroki et al., 1991). BGPa and CGM7
transfectants were a kind gift from M. Kuroki and Y. Mat-
suoka, Fukuoka University.
Flow cytometry analysis
Flow cytometry (Leiserson, 1985) of cloned G418-resis-
tant cells was performed with a fluorescence activated cell
scan (FACScan) flow cytometer (Becton Dickinson) using
the LysisII software for data processing. Cells were removed
from plastic dishes with NaCl/P, containing 0.5 mM EDTA.
All subsequent steps were performed at 4°C with NaCl/P,
containing 1.1 mM CaCl, and 0.4 mM MgSO^ and 3% fetal
calf serum (NaCl/P/fetal calf serum) 0.5 X 10" cells in 35 nl
NaCl/P/fetal calf serum were incubated with an excess of
mouse or rat monoclonal antibodies (0.25-1.25 ng) for
20 min. A monoclonal antibody of IgGl isotype (control
IgGl) directed against a non-biological hapten (Immunotech)
served as a negative control. After washing twice with 200 nl
ice-cold NaCl/P/fetal calf serum, 25 nl biotinylated anti-
mouse polyvalent Ig (Sigma) or anti-rat IgG (Amersham In-
ternational; both diluted 1: 50 with NaCl/P,/fetal calf serum)
were added to the cells for another 20 min followed by a
wash. Then the cells were washed as above and incubated
with 25 nl phycoerythrin-linked streptavidin (1: 80, Southern
Biotechnology Associates) for 20 min, washed and resus-
pended in 300 nl NaCl/P,/fetal calf serum for FACScan
analysis. Alternatively, anti-mouse IgG directly coupled to
phycoerythrin (1; 50, Southern Biotechnology Associates)
was used as second step antibody.
RESULTS
Cloning of CGMl cDNAs
Several CEA-related antigens not yet assigned to their
corresponding genes have been found in granulocytes (Ku-
roki et al., 1990a). As granulocytic precursor cells are known
to contain larger amounts of CEA-related mRNAs in com-
parison to mature granulocytes (Berling et al.. 1990), RNA
from leukocytes of a CML patient, which are enriched for
myeloid precursors, was used as template for generation of
full-length CGMl cDNAs by PCR. Two cDNA species were
isolated, sequenced and shown by comparison with the pub-
lished genomic sequence (Thompson et al., 1989) to code for
CGM 1. The sequence of the two cDNAs is shown in Fig. 1A
together with the deduced domain structure (Fig. IB). The
longer cDNA (CGM la) consists ofa 54-bp 5'-noncoding re-
gion, a 756-bp open reading frame, and 317-bp 3'-untrans-
lated region. It codes for a putative preprotein of 252 amino
acids with an M, of 27077. Compari.son of the deduced am-
ino acid sequence with other members of thc CEA family
(Thompson et al., 1991) revealed that the encoded protein
consists ofa 34-amino-acid leader peptide (L), a 108-atTiino-
acid IgV-like domain (N), a putative transmembrane domain
of 39 amino acids and a 71-amino-acid cytoplasmic domain,
but lacks immunoglobulin constant like (IgC) domains found
in most other members of the CEA family. Two potential
sites for A'-glycosylation are present in the N domain at con-
served positions in comparison with NCA-50/90 (Neumaier
et al., 1988). The sequence of the shorter cDNA (CGMlc;
1022 bp) shows two deletions of 53 and 52 bp, respectively.
The encoded protein (A/, 22780) is nearly identical to that of
CGM la with respect to the IgV-like (N) and transmembrane
(TM) domain, but differs in the cytoplasmic domain. The
cytoplasmic tail of CGMlc consists of only 31 amino acids
and has a different amino acid sequence. This sequence devi-
ation is caused by the 53-bp deletion at the border between
the putative transmembrane and cytoplasmic domains, which
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CSH1C . . . . . r - * " - . c . . . . f .
CGHIa 1 TCCtCMGCCCAGGCtCTTTTCCACACAGGACGAAAGAGCAGGCACCAGAGACCATGGGCCCCCCCTCAGCCTCTCCCCACACAGAATGCtTCCCCTCGCAGGGGCTTCTGCTCACAGCC
CSM1a ^ MetGlyProCroScrAlsSerProHisArsQIuCyslleProTrpGtnGlyLnjLeuLeuThrAla
CGHIc • Pro
r* • .
121 TCACTTCTAAACTTCTGGAACCCGCCCACCACTGCCAAGCTCACTATTGAATCCATGCCGCTCAGTGTCGCAGAGGGGAAGGAGGTGCTTCTACTTGTCCACAATCTCCCCCAGCATCTT
23 S«rL«uLeuA5nPh«IrpAan(>ro('roThrIhrAl»LysleuThrll«GluSerMetPro(.«iSerValAl«GluClyLysGluV»lL«iL«uL«uV«lKi»AsnLmi('roGlnHisLeu
241 TTTGGCTACAGCTGGTACAAAGGGGAAACAGTGGATGGCAACAGTCTAATTGTGGGATATGTAATAGGAACTCAACAAGCTACCCCAGGGGCCGCATACAGCGGTCGAGAGACAATATAC
6 } PheClyTyrSerTrpTyrlysGlyGluArgValAspGtyAsnSerLeuIleValGlyTyrVall leGlyThrGlnClnAlsTlirProGlyAtaAlaTyrScrGiyArsGluThrl leTyr
M 1 ACCAATCCATCCC1GCTGATCCAGAATGTCACCCAGAATGACATAGGATTCTACACCCTACAAGTCATAAAGTCAGATCTTGTGAATGAAGAAGCAACTGGACAGTTCCATGTATACCAA
103 ThrAsnAlaSerLeuL«ineGlnAsnValThrGlnlMinAspUeGly<>heTyrThrleuGlnVa(Uel.ysScrAspLeuValAsnCluGluAlaThrGlyGln(>heHisValIyrGln
r-» ™ . . . . . . . . . . . f r-» Cyt
U3 GluAsnAlaProGlylauProVatGlyAlaValAlaGlyUtValThrGlyValLeuValGlyValAlaLniValAlaAlaLcuVaLCysPheLeuLeuLeuAlaLysThrClyArgThr
Ar
ACCC
183 SirlleGlnArgAspleuLysGluGlnClnProGlnAlaLeuAlaPraGlyArgGlyProSerHisScrSerAlaPhcScrHrtSi-rProLeuSerSerAlaGlnAlaProLcuProAsn
gProTrpSerLeijProGlnLeuCysLeuleuA5pValProSerLeuHisCysLetjGlyProProThrGlnPro
I . . . . . _ . . . . G .
721 CCCAGGACAGCAGCTTCCATCTATGAGGAATTGCTAAAACATGACACAAACATTTACTGCCGGATGGACCACAAAGCAGAAGTGGCtTCTTAGCTTCCICCAGGAGCTGCTCCTGTGTGT
223 Pro«r»7hrAlaAlaSerl leTyrGluGluLeol .eul .ysHis*spIhrAsnI lrTyrCy! iAr9HetAspHislysAlaGluValAlaStr«"
GlnAspSerScrPheHisLeu***
M l TGATGGAGAGTC
961 CCCIG
10S1 ACCTGGGG1CACTTGGAAAGGATCTGAATAAAGGGGACCCTTCCTCG
L N TM Cyt
CGMla
pCGMIa
N TM Cyt ^*)
^m *
pCQMIC
500 bp
Fig. 1. Nuclwitide and deduced amino acid sequence (A) and domain organization (B) of the CGMla and CGMlc cDNAs. (A)
Nucleotides and amino ucids are numbered on the left. Domain borders (a.s deduced from exon borders) arc indicated by arrows, exon
borders by arrowheads. L, leader; N. N-terminal or IgV-like domain; TM, transmemhrane domain; Cyt, cytoplasmic domain. Stop codons
are indicated by asterisks. Nucleotide and resulting amino acid differences in CGMlc are shown above and below the CGMla sequence,
respectively. The sequences deleted in CGMlc are underlined. Alternative splice acceptor sites tised in CGM7 (see text) and CGMlc are
overlined. The polyadenylation signal is indicated by a broken line. (B) The coding regions of CGMla and CGMlc mRNA are shown as
boxes (for abbreviations see A). Similar amino acid sequences are indicated by identical patterns in the boxes. The amino acid sequence
denoted by a dotted box in the cytoplasmic domain of CGMla is also found in BGPa and BGPb (Thompson et al., 1991), the region
corresponding to the open box is deleted in the CGM7 cDNA (Kuroki et al., 1991). The polyadenylation signal sequences are marked by
arrows. The sizes of the cDNAs and the name of the corresponding clones are indicated underneath the RNA.
leads to a shift in the reading frame resulting in the creation resent errors introduced by Taq DNA polymerase during
of a new stop codon. The second deletion in CGMlc occurs PCR amplification. The exchange from a T lo C (position
directly 3' to this stop codon and has no influence on the 73) leads to Pro instead of Ser in the leader peptide. The
deduced amino acid sequence. Multiple putative targets for nucleotide changes at positions 697 and 703 result in an ex-
phosphorylation are present in the cytoplasmic domains of change of His for Leu and Leu for Pro, respectively.
CGMla and CGMlc. Whereas serine and threonine residues
exist in both sequences, tyrosine residues are only found in „ . • *• ^ *i. /-.^-.»,,
CGMla. These tyrosines lie within a sequenc'e context Genomic organization of the COM 1 gene
(YXJLXTYXJM; in one-letter code) which is similar to a In order to understand the mechanism by which the vari-
consensus sequence CYLYL' motif: YXJLXTYX.L/ I ) found able cytoplasmic domains are created we have determined
in the cytoplasmic domain of molecules known to be in- the borders of the exons coding for these regions by sequenc-
volved in signal transduction of multichain immune recog- ing (Table 1). The results indicate that the cytoplasmic do-
nition receptors (Keegan and Paul, 1992). In both predicted main of CGMla is encoded by four exons Cytl, Cyt2, Cyt3
cytopla.smic regions (assuming that Lysl78 is the first amino and Cyt4, the latter of which also contains the sequences for
acid ofthe cytoplasmic domain) Thrl79 lies within a consen- the 3'-untranslated region. The first deletion observed in the
sus sequence for protein kinase C pho.sphorylation (Woodget CGMlc cDNA can be explained by the splicing out of the
et a!., 1986) and a casein kina.se II phosphorylation site at Cytl exon. The second deletion is caused by usage of an
Ser228 can be predicted for CGMla (Pinna, 1990). The four alternative splice acceptor signal in Cyt4, which conforms
nucleotide differences, which are found between CGMla and only poorly with the consensus sequence for splice acceptors
CGMlc, are possibly due to alleiic variations or may rep- (Figs 1A and 2). Furthermore, the distances between the ex-
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ons of the CGM1 gene were determined by PCR and by
restriction endonuclease mapping. The data imply that the
CGMl gene spans a region of about 15 kb and is contained
within three £roRI DNA fragments of 2,7, 4,9 and 14,4 kb
which have been identified and mapjjed recently (Thompson
et al,, 1989; Tynan et al,, 1992), The size ofthe larger £a;RI
DNA fragment was detennined by hybridization of CGMl-
containing cosmid DNAs with an oligonucleotide from the
3'-untranslated region (data not shown),
CD66 but not CD67 antibodies identify epitopes
expressed by CGMl
The deduced amino acid sequence of the N-domain of
CGMl is very similar to that of NCA-50/90 (90% similarity;
Ncumaier et al,, 1988), Since it has recently been shown that
NCA-50/90 on granulocytes is recognized by CD66 anti-
bodies (see introduction) and NCA-95, another NCA species
reacts with CD67 antibodies, we decided to test whether
CD66 and CD67 epitopes are also present on the CGMl
protein. To achieve this, we transfected HeLa cells with a
CGMl a cDNA-containing expression vector together with a
G418 resistance-conferring plasmid, G418-resistant cell
clones were analyzed for CGM1 expression by flow cytome-
try using polyclonal anti-CEA and anti-NCA antisera. One
HeLa cell clone was found by Western blot analyses to ex-
press a CGMl protein of 30-35 kDa (data not shown). This
CGMl-expressing HeLa cell clone, together with control
HeLa transfectants which express CEA (HeLa-CEA), NCA-
50/90 (HeLa-NCA), CGM6 (HeLa-CGM6) and the neo gene
alone (HeLa-Neo) as well as a BGPa- and a CGM7-produc-
ing CHO cell line, were used for flow cytometric analysis
with antibodies assigned to CD66 (CLBgranIO) and CD67
(BI3,9), The BGPa transfectant cell line was included since
the BGP gene in granulocytes probably codes for the CD66
antigen NCA-160 (see Discussion), The CD66, but not the
CD67, antibody reacted with the CGMl-expressing HeLa
cell clone (Fig, 3), Tbe former crossreacted with CEA, NCA
and BGPa transfectants to a varying extent, whereas the
CD67 antibody reacted only with the CGM6-expressing cell
line, A second CD66 antibody (YTH71,3,2) exhibited the
same antigen recognition pattern as CLBgranIO (data not
shown).
Analysis of tbe expression pattern of CGMl
Since the two CGMl cDNA clones were isolated from a
mixture of white blood cells from a CML patient, we ana-
lysed various types of leukocytes for the presence of CGMl
mRNA by the PCR technique, Oligonucleotides derived from
the 5'- and 3'-untranslated region of CGMl mRNA were
used as primers. These oligonucleotides allow the specific
detection of both splice variants CGMla and CGMlc as 994-
bp and 889-bp DNA fragments, respectively. The intactness
oi" the RNA samples was confirmed by analyzing for the
presence of ^-actin mRNA, This reaction was carried out
both with and without reverse transcription prior to PCR to
detect any genomic DNA contamination with processed fi-
actin pseudogenes (Ng et al,, 1985), The ^-actin cDNA frag-
ments, which were obtained after reverse transcription, are
shown (Eig, 4B), No or only weak signals were found when
reverse transcriptase was omitted (data not shown). We found
CGMla mRNA to be present in normal granulocytes and
leukocytes of CML patients (Eig, 4A, lanes 6-10), CGMlc
mRNA could be detected in total leukocyte RNA from one
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CGM1b
CGMla
CGMlc
Fig. 2. Exon structure of the CGMl gene. Exons corresponding to the 5'- and 3'-untranslated regions (UT) and to coding regions are
symbolized by open and fiUed-in boxes, respectively (for abbreviations see legend to Fig. IA). The transcriptional start site has not been
determined experimentally. Therefore, the size of the first exon is only approximate. E, K, £coRI and Kpnl restriction endonuclease sites.
Only the Kpnl sites within the 14.4-kb EcoRl DNA fragment have been detennined. Splice events leading to CGMla, CGMlb (Kuroki et
al., 1991) and CGMlc are indicated by lines (continuous lines, CGMlb- and CGMla-specific splice events; dotted lines, splice events
observed for CGMlc; dashed lines, splice events common to CGMla and CGMlc). Stop codons are marked by an open (CGMlb) or
closed circle (CGMlc) or a filled-in square (CGMla).
HaLa-Nao HaU-CEA HeLa-NCA
(NCA-90)
HeU-CGM6
(NCA-9S)
HeUCQMI CHO CHO-CGM7 CHO-BQPa
(NCA-160)
CLBgraniO
(CD66)
B13.9
(CD67)
fluorescence intensity
Fig. 3. Determination of the reactivity of CD66 and CD67 mAhs with transfectants expressing various members of the CEA family
by flow cytometry. Stable HeLa and CHO cell transfectants expressing members of the CEA gene family (deviating antigen names are
indicated in brackets) were analysed with mAb CLBgraniO (CD66) or with B13.9 (CD67). HeLa cells transfected with pSV2neo (HeLa-
Neo) alone and the parental CHO cell line served as negative controls. More than 95% of the negative control cells show a relative
fluorescence of less than 30 which Is indicated by the broken vertical line. The CGM7 transfectant was proved to express the CGM7
protein using mAb D14HD11, which is known to react with the CGM7 antigen (P. Jantscheff, unpublished results; data not shown).
CML patient only (Fig. 4A, lane 7). The identity of the am-
plification products obtained was confirmed by stringent hy-
bridisation with an oligonucleotide derived from the trans-
membrane domain of CGMl (data not shown). Using total
RNA from monocytes and lymphocytes as templates, no sig-
nals were obtained (Fig. 4A, lanes 4, 5).
In order to analyze the expression pattern of CGMl
further, we tested RNAs isolated from a number of tumors
and metastases derived from all three germ layers as well as
a few normal tissues. In contrast to the results obtained with
RNA from CML leukocytes or normal granulocytes, no
CGMl mRNAs could be detected in the following tissues:
adenocarcinomas (one each) of the pancreas, lung, kidney,
stomach and colon, three mucinous carcinomas of the ovary,
one small-cell and one large-cell carcinoma of the lung, one
squamous carcinoma of the gall bladder and one of the lung,
one hepatocellular carcinoma, one osteosarcoma, one sar-
coma of the ovary, one teratoma, one melanoma and one
testis carcinoma as well as normal spleen, placenta and co-
Ionic mucosa.
These data indicate that the CGMl gene is specifically
expressed in the granulocytic lineage. Therefore, we tested
whether the CGMl protein can be detected on the surface of
mature granulocytes. Since several NCA-related antigens are
expressed on granulocytes, CGMl-specific antibodies are
needed. For this purpose we analyzed a large panel of mAbs
(87) prepared against CEA, CEA-crossreacting antigens or
various CEA/NCA-expressing cell lines for the presence of
CGMl-specific antibodies. The panel of antibodies was
available from the groups who participated in a workshop
for the characterization of antibodies directed against CEA-
related antigens (Nap et al., 1992). Two of the antibodies,
which recognized CGMl on transfectants (mAb Tu2 and
mAb 73) were only crossreactive with CEA, but not with
NCA, CGM6, CGM7 nor with BGPa transfectants. However,
crossreaction with the product of CGM2. the only other ex-
pressable gene of the CEA subgroup, cannot be ruled out at
present (Thompson et al., 1991). Since CEA is not present
on granulocytes, these mAbs were used to analyze surface
expression of the CGMl product by flow cytometry. The re-
sults shown in Fig. 5 suggest that the CGMl product is pre-
sent on the surface of mature granulocytes although in low
amounts. This is inferred from the observation that granulo-
cytes show only a low fluorescence signal when analyzed
with Tu2 and mAb 73 compared to the signal obtained with
mAb NI that reacts with both CGMl and NCA-90, but not
with CEA, BGPa and the products of CGM6 and CGM7
(Fig. 5; Berling et al., 1990, and unpublished results). This
is not due to a higher affinity of NI, since mAbs NI, Tu2 and
73 recognize the CGMl transfectant equally well (Fig. 5).
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Fig. 4. Analysis of CGMl expression in hematopoietic cells by
PCR. (A) For the specific amplification, oligonucleotides from the
5'- and 3'-unlranslated region of CGMl mRNA were used. As posi-
tive controls 6 ng supercoiled pCGMla (lane 2) and pCGMlc cDNA
(lane 1) plasmids and total RNA from the HeLa-CGMIa transfectant
(lane 3) were tested. Total RNA from monocytes, lymphiKytes and
granulocytes (lanes 4 - 6 ) of healthy donors and from leukocytes of
four different CML patients (lanes 7-10) was analyzed. 20% of Ihe
amplification products (except for CGMl cDNAs and the CMLI
sample where 2% and 70%, respectively, were used) were separated
by electrophoresis on a 1.8% agarose gel, stained with ethidium
bromide and visualized under ultraviolet light. The integrity of the
RNA samples was examined hy amplification of a //-actin mRNA
fragment after reverse tran.scription (B). ////icll-digested bacterio-
phage FX174 DNA was used as size marker (lane 11).
Cranulocytes
HeLa-CGM1
HeLa-Neo
MONOCLONAL ANTIBODtES
Fig.5. Expre.ssion of CGMl on the surface of granulocytes. The
expression of CGMl on granulocytes was determined hy FACScan
analyses (hatched columns). HeLa transfectants expressing CGMl
(HeLa-CGM 1; Illled-in columns) or transfected with pSV2neo alone
(HeLa-Neo; open columns) served as positive and negative controls,
respectively. As a further negative control, cells were incubated with
an irrelevant isotype matched mAh (control). The mean fluo-
rescences of duplicates from two independent experiments are
shown. Bars indicate the deviations from the mean values.
DISCUSSION
In this paper we describe the isolation of two CGMl
cDNA clones, which encode CGMl i.soforms (CGMla and
CGMlc) with different cytoplasmic domains. CGMla is es-
sentially identical to cDNA clone W264, which was recently
isolated from a normal white blood cell cDNA library al-
though seven nucleotide differences were found (Kuroki et
al., 1991). Two out of four differences in the coding region
result in amino acid changes. They could repre.sent alleiic
variations or errors introduced during PCR amplification. A
second CGMl splice variant (CGMlb; W282) described by
Kuroki et al. (1991), which in contrast to CGMla contains
part of an IgC-like domain (type A) and sequences of the
downstream intron, is predicted to encode a secreted protein
since the A dotnain exon contains a nonsense mutation (see
Fig. 2). Analysis of the exon organization of the CGMl gene
reveals that the cytoplasmic region of CGMla is encoded by
four small exons. In CGMlc, the first cytoplasmic dotnain
exon (Cytl) is spliced out. thus creating a shift in the reading
frame and leading to a different amino acid sequence. Se-
quences similar to the Cytl exon of CGMl are also found
in human |BGPa or TM-1 CEA and BGPb or TM-2 CEA
(Thompson et al., 1991; Barnett et al., 1989)| and rodent
BGP splice variants [ectoATPase (Lin and Guidotti, 1989)],
Deletion of this exon in BGP splice variants (BGPc, BGPd)
al.so results in shorter cytoplasmic dotiiains, although with a
different sequence compared to CGMlc, since the sequence
following the Cytl region in BGP is not homologous to Cyt2,
Cyt3 or Cyt4. Although identical with CGMla in its overall
domain organization, the CGM7 (old name; W236) product
contains an eight-amino-acid deletion in the cytoplasmic do-
tnain (Kuroki et al., 1991). From the presence of a perfect
splice acceptor signal within the Cyt3 exon of CGMl
(Fig. IA), it can be inferred that altemative splicing is prob-
ably the cause for the in-frame deletion in the CGM7 prod-
uct.
It remains to be resolved whether the different cytoplas-
mic domains of CGM1-. CGM7- and BGP-encoded proteins
are of any functional importance. In this regard, however, it
may be interesting that analysis of the primiu'y structures has
revealed the presence of a conserved potential protein ki-
nase C phosphorylation site (Woodget et al., 1986) at the N-
terminus of the cytoplasmic domains of all transmembrane
isoforms of the CEA family so far described (Barnett et al.,
1989; Lin and Guidotti, 1989; Turbide et al., 1991; Kuroki
et al., 1991; McCuaig et al., 1992). Multiple protein kinase C
and ca.sein kinase II phosphorylation sites (Pinna, 1990) are
also conserved at variable positions in the cytoplasmic tails.
Since phosphorylation seems to influence the activity of ad-
hesion molecules, as found for the /i-subunit of CD11/CD18
integrins (Hibbs et al., 1991), the adhesive properties of the
CEA subgroup members could be modulated by differential
splicing within their cytoplasmic domains. Differential splic-
ing could also affect the potential signal transduction prop-
erty of CGML since the 'YLYL' motif, which has been
shown to be associated with signal transduction (Keegan and
Paul, 1992), is only present in CGMla. Interestingly, the
BGP Lsoforms BGPa and BGPb and the corresponding rat
homologues (Barnett et al., 1989; Culic et al., 1992) also
contain a similar motif in their cytoplasmic domains in a
region without any obvious similarity to CGMla. However,
a common ancestry of the cytoplasmic domains with the
'YLYL' motif is suggested by the observation that a type-0
intron separates the codons for the first Tyr and Leu within
thc motif in the genes for CGMl, mouse CD3i: and CD3J
(Fig. IA; Baniyash et al., 1989; van den Eisen et al., 1986).
The investigation of the immunological relationship of
the CGMl product with other members of the CEA family
using stable HeLa and CHO transfectants expressing individ-
ual members revealed that the CGMl antigen carries the
CD66 epitope. Since the extracellular part of CGMl consists
only of an IgV-like N-domain, the CD66 epitope must be
located in the N domain of NCA-50/90 and NCA-160. The
binding of CD66 antibodies to the BGP transfectant and to a
160-kDa protein of granulocytes strongly supports the con-
clusion of Drzeniek et al. (1991) that NCA-160 on granulo-
cytes is a product of the BGP gene, although a different mol-
ecular mass has been reported for the deglycosylated forms
of NCA-160 and BGPa (Audette et al.. 1987; Kuroki et al..
1990a, 1991). Thus to date, the products of four genes (CEA,
NCA, BGP and CGMl) bear the epitope(s) recognized by the
CD66 antibodies. Therefore, the presence of CGMl in low
but significant amounts on the surface of granulocytes has to
be taken into account when the function of CEA-related anti-
gens is studied with CD66 antibodies (Kuijpers et al.. 1992).
Analysis of the expression pattem of CGMl revealed that
CGMl transcripts could only be detected in normal granulo-
cytes and leukocytes of CML patients, but not in lympho-
cytes, monocytes nor in other tissues. The exclusive presence
of mRNA in cells of the granulocytic lineage is in agreement
with the fact that CGMl belongs to CD66 which has been
described as a granulocyte-sjjecific cluster of differentiation
(Knapp et al.. 1989). CGMlc mRNA in addition to CGMla
could only be detected in leukocytes of one CML patient.
Since the ratio of different myeloid precursor cells in periph-
eral blood can vary in CML patients (Raskind and Fialkow.
1987). this result suggests that CGMl splice variants are
stage-specifically expressed. However, more samples have to
be analysed to clarify this.
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